John Barbara
Medical · Gilroy, CANPI 1972882546
Payments from drug & device makers
Across 423 payments — averaging $20.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Boehringer Ingelheim$1K
- Novo Nordisk$871
- GSK$767
- Amgen$741
- Pfizer$586
- plus $3K from 29 others
What the payments were for
- Food & beverage$8,593100%
- Education$310%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 50 | $1,473 |
| Boehringer Ingelheim | 54 | $1,139 |
| Novo Nordisk | 54 | $871 |
| GSK | 45 | $767 |
| Amgen | 38 | $741 |
| Pfizer | 31 | $586 |
| Merck | 18 | $409 |
| AbbVie | 18 | $389 |
| Lilly USA, LLC | 23 | $337 |
| Abbott | 18 | $302 |
| Bayer | 10 | $216 |
| Amarin Pharma, Inc. | 8 | $147 |
| Mylan Specialty L.p. | 4 | $145 |
| Exact Sciences | 6 | $133 |
| Philips North America LLC | 6 | $120 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $89 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Sanofi-aventis U.S. LLC | 4 | $81 |
| Viiv Healthcare Company | 3 | $66 |
| Alfasigma USA, Inc. | 3 | $57 |
| Xeris Pharmaceuticals, Inc. | 3 | $56 |
| Paratek Pharmaceuticals, Inc. | 2 | $54 |
| Avanir Pharmaceuticals, Inc. | 2 | $52 |
| Kowa Pharmaceuticals America, Inc. | 3 | $51 |
| Heartflow, Inc. | 1 | $36 |
| Dexcom, Inc. | 1 | $33 |
| Johnson & Johnson | 2 | $29 |
| Si-bone, Inc. | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Novartis | 1 | $21 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Verity Pharmaceuticals Inc. | 1 | $15 |
| Globus Medical | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,624 in reported general payments places this provider in the 90th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 149 | $169,069 |
| OzempicSemaglutide | 98 | $111,280 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 67 | $75,214 |
| EliquisApixaban | 58 | $64,631 |
| JanuviaSitagliptin Phosphate | 43 | $61,344 |
| TrulicityDulaglutide | 27 | $38,957 |
| MounjaroTirzepatide | 34 | $35,583 |
| Repatha SureclickEvolocumab | 24 | $29,588 |
| LinzessLinaclotide | 31 | $25,856 |
| NuedextaDextromethorphan Hbr/Quinidine | 13 | $20,126 |
| FarxigaDapagliflozin Propanediol | 15 | $17,881 |
| Alosetron Hcl | 12 | $12,649 |
| VascepaIcosapent Ethyl | 19 | $11,187 |
| Tresiba Flextouch U-200Insulin Degludec | 20 | $10,346 |
| Rosuvastatin Calcium | 480 | $9,330 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $1,139 | $169,069149 claims |
| Novo NordiskOzempic | $871 | $111,28098 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $767 | $82,06379 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $337 | $74,54061 claims |
| PfizerEliquis | $586 | $64,63158 claims |
| MerckJanuvia | $409 | $61,34443 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $1,473 | $29,36042 claims |
| AbbVieLinzess | $389 | $25,85631 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $52 | $20,12613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,087 medical providers in California.
Other medical in Gilroy
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.